These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 9516895)
21. Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. Hughes R; Goldkorn A; Masoli M; Weatherall M; Burgess C; Beasley R Lancet; 2003 Jun; 361(9375):2114-7. PubMed ID: 12826434 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Lipworth BJ; Clark RA; Dhillon DP; Moreland TA; Struthers AD; Clark GA; McDevitt DG Eur J Clin Pharmacol; 1989; 37(6):567-71. PubMed ID: 2693116 [TBL] [Abstract][Full Text] [Related]
23. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma. Bjermer L; Rosenborg J; Bengtsson T; Lötvall J Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810 [TBL] [Abstract][Full Text] [Related]
24. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms. Boger E; Fridén M J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):1-12. PubMed ID: 29878860 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of cumulative single doses of inhaled salbutamol enantiomers in asthmatic subjects. Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ Pulm Pharmacol Ther; 1999; 12(6):353-62. PubMed ID: 10587476 [TBL] [Abstract][Full Text] [Related]
26. Mouthpiece versus facemask for delivery of nebulized salbutamol in exacerbated childhood asthma. Kishida M; Suzuki I; Kabayama H; Koshibu T; Izawa M; Takeshita Y; Kurita F; Okada M; Shinomiya N; Aoki T J Asthma; 2002 Jun; 39(4):337-9. PubMed ID: 12095184 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and side effects of salbutamol in acute asthma in children: comparison of oral route and two different nebulizer systems. Scalabrin DM; Naspitz CK J Asthma; 1993; 30(1):51-9. PubMed ID: 8428859 [TBL] [Abstract][Full Text] [Related]
28. [Comparative therapeutic effect of bronchodilator aerosols and salbutamol cyclocaps]. Ninković M; Bjelajac D; Ranković B; Dangubić V; Plavec G Vojnosanit Pregl; 1993; 50(6):589-92. PubMed ID: 8197732 [TBL] [Abstract][Full Text] [Related]
29. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers. Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454 [TBL] [Abstract][Full Text] [Related]
30. The use of water as a diluent for bronchodilator nebuliser solutions. Kwong T; Town I; Windom H; Beasley R N Z Med J; 1990 Jun; 103(892):290-1. PubMed ID: 2366999 [TBL] [Abstract][Full Text] [Related]
31. Spirometry in children with asthma and/or allergic rhinitis: comparison of FEF25-75% with the standard measures. Eke Gungor H; Sahiner UM; Altuner Torun Y Minerva Pediatr; 2019 Apr; 71(2):103-109. PubMed ID: 26365818 [TBL] [Abstract][Full Text] [Related]
33. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
34. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. van der Woude HJ; Winter TH; Aalbers R Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351 [TBL] [Abstract][Full Text] [Related]
35. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study. Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051 [TBL] [Abstract][Full Text] [Related]
36. Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels. Rodrigo G; Rodrigo C Am J Emerg Med; 1996 Mar; 14(2):144-50. PubMed ID: 8924135 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer. Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619 [TBL] [Abstract][Full Text] [Related]
38. Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin Evohaler) in moderate to severe asthmatics. Lipworth BJ; Sims EJ; Taylor K; Cockburn W; Fishman R Br J Clin Pharmacol; 2005 Jan; 59(1):5-13. PubMed ID: 15606434 [TBL] [Abstract][Full Text] [Related]
39. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulised solution. Zainudin BM; Biddiscombe M; Tolfree SE; Short M; Spiro SG Thorax; 1990 Jun; 45(6):469-73. PubMed ID: 2392793 [TBL] [Abstract][Full Text] [Related]
40. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. Aziz I; Hall IP; McFarlane LC; Lipworth BJ J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]